NPI: 1033309372 · BURBANK, CA 91505 · Professional Counselor · NPI assigned 08/01/2007
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 08/01/2007 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 200 | $820.85 |
| 2019 | 1,353 | $26K |
| 2020 | 33,387 | $314K |
| 2021 | 94,580 | $1.03M |
| 2022 | 79,295 | $928K |
| 2023 | 13,483 | $155K |
| 2024 | 1,128 | $16K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 140,507 | 129,206 | $1.12M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 26,185 | 24,035 | $619K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 26,663 | 25,045 | $302K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,419 | 2,413 | $112K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,220 | 4,197 | $108K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,263 | 2,991 | $47K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,986 | 1,900 | $45K |
| 90715 | 672 | 671 | $20K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,907 | 3,802 | $17K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 512 | 490 | $16K |
| 90674 | 807 | 807 | $13K | |
| 90746 | 177 | 177 | $11K | |
| 90686 | 443 | 442 | $7K | |
| 90707 | 106 | 106 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 173 | 172 | $5K |
| 99201 | 215 | 215 | $3K | |
| 86580 | 1,375 | 1,327 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 43 | 42 | $3K |
| 90682 | 67 | 67 | $2K | |
| 90734 | 28 | 28 | $2K | |
| 99401 | 240 | 232 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 103 | 52 | $935.06 |
| 3074F | 1,559 | 1,491 | $823.26 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 121 | 120 | $777.22 |
| 90480 | 49 | 49 | $718.80 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 24 | 24 | $672.17 |
| 0004A | 35 | 35 | $480.00 | |
| 0031A | 17 | 17 | $480.00 | |
| 0064A | 71 | 70 | $465.00 | |
| 3078F | 1,323 | 1,273 | $272.99 | |
| 1159F | 1,171 | 1,119 | $231.15 | |
| 81002 | 123 | 119 | $211.04 | |
| 1036F | 1,851 | 1,746 | $177.14 | |
| 3008F | 1,102 | 1,053 | $86.06 | |
| 1160F | 1,111 | 1,050 | $73.76 | |
| 3075F | 118 | 118 | $69.29 | |
| 0083A | 33 | 33 | $68.50 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 16 | 12 | $52.45 |
| 91308 | 92 | 89 | $40.00 | |
| 0081A | 76 | 76 | $40.00 | |
| 0082A | 50 | 50 | $39.60 | |
| 3079F | 349 | 342 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 24 | 24 | $0.00 |